跳到正文
Swissmedic 药品质量与 GMP 更新·精选AI 评分70

Swissmedic:自2026年11月15日起原料药须预先在 EMA SMS 数据库注册,方可列入生产许可和 GMP 证书

Adaptations required for issuing establishment licences and GMP certificates for manufacturers of active substances

AI 导读

Swissmedic 于2026年10月1日说明,自2026年11月15日起,原料药须预先在 EMA 的 SMS 数据库注册,否则 Swissmedic 将无法将其列入生产许可和 GMP 证书。

推荐理由

材料列出原料药须预先在 EMA SMS 数据库注册的新要求及企业提交清单的途径,便于核对自身申请与本厂原料药信息。

正文 · 原文

Adaptations required for issuing establishment licences and GMP certificates for manufacturers of active substances

As of 15 November 2026, the prior registration of active substances in the EMA SMS database (Substances Management Services) will become a mandatory requirement for their inclusion in establishment licences and GMP certificates

01.10.2026

From now on, owing to modifications in the EudraGMDP database, active substances that have to be listed in section 3.8 of establishment licences and GMP certificates will have to be registered in advance in the Substance Management Services (SMS) active substances database of the European Medicines Agency (EMA) (SPOR Web UI (europa.eu)).

As of 15 November 2026, Swissmedic will no longer be able to issue establishment licences and GMP certificates with a list of active substances if the submitted active substances have not been registered in advance in the SMS active substances database. This applies to both hardcopy and electronic versions (SwissGMDP or EudraGMDP).

This principle applies regardless of whether documents are being issued for the first time (application for first establishment licence) or in response to applications for a change to an existing licence or following an inspection. It is therefore essential that all active substances listed in Swiss manufacturers’ establishment licences / GMP certificates are registered in the SMS database.

As of today, manufacturers of active substances must:

Active substances already registered in the SMS active substances database can be downloaded as an Excel table (SMS Export lists).

If any active substance has not yet been registered in SMS, companies can submit a request for registration of an active substance via the EMA Service Desk using the Substance Request Form.

Swissmedic is not responsible for the management of active substances registered in the SMS database. Affected companies must ensure that the responsible staff members within their organisation have registered for an EMA account and submitted a request for a SPOR role.

The links below provide additional information on the SMS database and the associated services.

来源:Swissmedic 药品质量与 GMP 更新 · swissmedic.ch